Sfoglia per Autore
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?
2021-01-01 Tedeschi, Alessandra; Frustaci, Anna Maria; Mauro, Francesca Romana; Chiarenza, Annalisa; Coscia, Marta; Ciolli, Stefania; Reda, Gianluigi; Laurenti, Luca; Varettoni, Marzia; Murru, Roberta; Baratè, Claudia; Sportoletti, Paolo; Greco, Antonino; Borella, Chiara; Rossi, Valentina; Deodato, Marina; Biagi, Annalisa; Zamprogna, Giulia; Curto Pelle, Angelo; Lapietra, Gianfranco; Vitale, Candida; Morelli, Francesca; Cassin, Ramona; Fresa, Alberto; Cavalloni, Chiara; Postorino, Massimiliano; Ielo, Claudia; Cairoli, Roberto; Di Raimondo, Francesco; Montillo, Marco; Del Poeta, Giovanni
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study
2021-01-01 Visentin A.; Mauro F.R.; Cibien F.; Vitale C.; Reda G.; Fresa A.; Ciolli S.; Pietrasanta D.; Marchetti M.; Murru R.; Gentile M.; Rigolin G.M.; Quaglia F.M.; Scarfo L.; Sportoletti P.; Pravato S.; Piazza F.; Coscia M.; Laurenti L.; Molica S.; Foa R.; Cuneo A.; Trentin L.
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia
2021-01-01 Vitale C.; Boccellato E.; Comba L.; Jones R.; Perutelli F.; Griggio V.; Coscia M.
Real life use of bendamustine in elderly patients with lymphoid neoplasia
2021-01-01 Dogliotti I.; Ragaini S.; Vassallo F.; Boccellato E.; De Luca G.; Perutelli F.; Boccomini C.; Clerico M.; Botto B.; Grimaldi D.; Orsucci L.; Ferrero S.; Vitale C.; Ferrero D.; Coscia M.; Cavallo F.
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs
2021-01-01 Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia
B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide
2021-01-01 Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, Jonathan Weiss, Sandra Robrecht, Robert Eckert, Javier de la Serna, Marta Crespo, Marta Coscia, Candida Vitale, Sebastian Böttcher, Gesche Weppner, Matthias Ritgen, Stephan Stilgenbauer, Eugen Tausch, Kirsten Fischer, Michael Hallek, Barbara Eichhorst, Monika Brüggemann, Carmen Diana Herling
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll
2021-01-01 Vitale C.; Griggio V.; Riganti C.; Todaro M.; Kopecka J.; Jones R.; Salvetti C.; Boccellato E.; Perutelli F.; Voena C.; Godio L.; Boccadoro M.; Coscia M.
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib
2021-01-01 Mauro F.R.; Giannarelli D.; Visentin A.; Reda G.; Sportoletti P.; Frustaci A.M.; Chiarenza A.; Ciolli S.; Vitale C.; Laurenti L.; De Paoli L.; Murru R.; Gentile M.; Rigolin G.M.; Levato L.; Giordano A.; Del Poeta G.; Stelitano C.; Ielo C.; Noto A.; Guarente V.; Molica S.; Coscia M.; Tedeschi A.; Gaidano G.; Cuneo A.; Foa R.; Martelli M.; Girmenia C.; Gentile G.; Trentin L.
Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib
2021-01-01 Vitale, Candida; Gibbons, Jamie Lynn; Ferrajoli, Alessandra
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
2021-01-01 Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis , David Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, José A. García-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K. Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P Kater, Sabina Kersting, Jorge Labrador, Deepesh Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto Lopez-Garcia, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R. Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten U. Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs
2020-01-01 Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M.
Treatment of chronic lymphocytic leukemia in the new drugs era: the state of art in the Italian landscape
2020-01-01 Morelli F, Innocenti I, Autore F, Fresa F, Tomasso A, Piciocchi A, Frustaci AM, Trentin L, Mauro FR, Schiattone L, Visentin A, Del Poeta G, Reda G, Rigolin GM, Ibatici A, Ciolli S, Vitale C, Sportoletti P, Murru R, Levato L, Gentile M, D’Arena G, Coscia M, Villa MR, Fontana R, Efremov D, Tedeschi A, Scarfò L, Cuneo A, Foà R, Laurenti L
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
2020-01-01 Cerrano M.; Ruella M.; Perales M.-A.; Vitale C.; Faraci D.G.; Giaccone L.; Coscia M.; Maloy M.; Sanchez-Escamilla M.; Elsabah H.; Fadul A.; Maffini E.; Pittari G.; Bruno B.
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia
2020-01-01 Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, Coscia M
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy
2020-01-01 Porrazzo M.; Nicolai E.; Riminucci M.; Vitale C.; Coscia M.; De Paoli L.; Rago A.; Buscicchio G.; Maestrini G.; Ligia S.; Di Prima A.; Corsi A.; Caronna R.; Gaidano G.; Mauro F.R.
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)
2020-01-01 Mauro F.R.; Giannarelli D.; Galluzzo C.M.; Vitale C.; Visentin A.; Riemma C.; Rosati S.; Porrazzo M.; Pepe S.; Coscia M.; Trentin L.; Gentile M.; Raponi S.; Micozzi A.; Gentile G.; Baroncelli S.
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells
2020-01-01 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
2020-01-01 Scarfo L.; Chatzikonstantinou T.; Rigolin G.M.; Quaresmini G.; Motta M.; Vitale C.; Garcia-Marco J.A.; Hernandez-Rivas J.A.; Miras F.; Baile M.; Marquet J.; Niemann C.U.; Reda G.; Munir T.; Gimeno E.; Marchetti M.; Quaglia F.M.; Varettoni M.; Delgado J.; Iyengar S.; Janssens A.; Marasca R.; Ferrari A.; Cuellar-Garcia C.; Itchaki G.; Spacek M.; De Paoli L.; Laurenti L.; Levin M.-D.; Lista E.; Mauro F.R.; Simkovic M.; Van Der Spek E.; Vandenberghe E.; Trentin L.; Wasik-Szczepanek E.; Ruchlemer R.; Bron D.; De Paolis M.R.; Del Poeta G.; Farina L.; Foglietta M.; Gentile M.; Herishanu Y.; Herold T.; Jaksic O.; Kater A.P.; Kersting S.; Malerba L.; Orsucci L.; Popov V.M.; Sportoletti P.; Yassin M.; Pocali B.; Barna G.; Chiarenza A.; dos Santos G.; Nikitin E.; Andres M.; Dimou M.; Doubek M.; Enrico A.; Hakobyan Y.; Kalashnikova O.; Ortiz Pareja M.; Papaioannou M.; Rossi D.; Shah N.; Shrestha A.; Stanca O.; Stavroyianni N.; Strugov V.; Tam C.; Zdrenghea M.; Coscia M.; Stamatopoulos K.; Rossi G.; Rambaldi A.; Montserrat E.; Foa R.; Cuneo A.; Ghia P.
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
2020-01-01 Gentile M.; Martino E.A.; Visentin A.; Coscia M.; Reda G.; Sportoletti P.; Mauro F.R.; Laurenti L.; Varettoni M.; Murru R.; Chiarenza A.; Vigna E.; Mendicino F.; Lucia E.; Bossio S.; Recchia A.G.; Moia R.; Pietrasanta D.; Loseto G.; Consoli U.; Scortechini I.; Rossi F.M.; Zucchetto A.; Al-Janazreh H.; Vitale C.; Tripepi G.; D'Arrigo G.; Angeletti I.; Bomben R.; Neri A.; Cutrona G.; Fronza G.; Di Raimondo F.; Gaidano G.; Cuneo A.; Foa R.; Ferrarini M.; Trentin L.; Gattei V.; Morabito F.
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
2020-01-01 Salvetti C, Vitale C, Griggio V, Drandi D, Bonello L, Cavallo F, Bomben R, Gattei V, Zamò A, Coscia M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? | 2021 | Tedeschi, Alessandra; Frustaci, Anna Maria; Mauro, Francesca Romana; Chiarenza, Annalisa; Coscia, Marta; Ciolli, Stefania; Reda, Gianluigi; Laurenti, Luca; Varettoni, Marzia; Murru, Roberta; Baratè, Claudia; Sportoletti, Paolo; Greco, Antonino; Borella, Chiara; Rossi, Valentina; Deodato, Marina; Biagi, Annalisa; Zamprogna, Giulia; Curto Pelle, Angelo; Lapietra, Gianfranco; Vitale, Candida; Morelli, Francesca; Cassin, Ramona; Fresa, Alberto; Cavalloni, Chiara; Postorino, Massimiliano; Ielo, Claudia; Cairoli, Roberto; Di Raimondo, Francesco; Montillo, Marco; Del Poeta, Giovanni | |
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study | 2021 | Visentin A.; Mauro F.R.; Cibien F.; Vitale C.; Reda G.; Fresa A.; Ciolli S.; Pietrasanta D.; Marchetti M.; Murru R.; Gentile M.; Rigolin G.M.; Quaglia F.M.; Scarfo L.; Sportoletti P.; Pravato S.; Piazza F.; Coscia M.; Laurenti L.; Molica S.; Foa R.; Cuneo A.; Trentin L. | |
Impact of immune parameters and immune dysfunctions on the prognosis of patients with chronic lymphocytic leukemia | 2021 | Vitale C.; Boccellato E.; Comba L.; Jones R.; Perutelli F.; Griggio V.; Coscia M. | |
Real life use of bendamustine in elderly patients with lymphoid neoplasia | 2021 | Dogliotti I.; Ragaini S.; Vassallo F.; Boccellato E.; De Luca G.; Perutelli F.; Boccomini C.; Clerico M.; Botto B.; Grimaldi D.; Orsucci L.; Ferrero S.; Vitale C.; Ferrero D.; Coscia M.; Cavallo F. | |
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs | 2021 | Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia | |
B-cell Acute Lymphoblastic Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Lenalidomide | 2021 | Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, Jonathan Weiss, Sandra Robrecht, Robert Eckert, Javier de la Serna, Marta Crespo, Marta Coscia, Candida Vitale, Sebastian Böttcher, Gesche Weppner, Matthias Ritgen, Stephan Stilgenbauer, Eugen Tausch, Kirsten Fischer, Michael Hallek, Barbara Eichhorst, Monika Brüggemann, Carmen Diana Herling | |
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll | 2021 | Vitale C.; Griggio V.; Riganti C.; Todaro M.; Kopecka J.; Jones R.; Salvetti C.; Boccellato E.; Perutelli F.; Voena C.; Godio L.; Boccadoro M.; Coscia M. | |
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib | 2021 | Mauro F.R.; Giannarelli D.; Visentin A.; Reda G.; Sportoletti P.; Frustaci A.M.; Chiarenza A.; Ciolli S.; Vitale C.; Laurenti L.; De Paoli L.; Murru R.; Gentile M.; Rigolin G.M.; Levato L.; Giordano A.; Del Poeta G.; Stelitano C.; Ielo C.; Noto A.; Guarente V.; Molica S.; Coscia M.; Tedeschi A.; Gaidano G.; Cuneo A.; Foa R.; Martelli M.; Girmenia C.; Gentile G.; Trentin L. | |
Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib | 2021 | Vitale, Candida; Gibbons, Jamie Lynn; Ferrajoli, Alessandra | |
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study | 2021 | Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis , David Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, José A. García-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K. Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P Kater, Sabina Kersting, Jorge Labrador, Deepesh Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto Lopez-Garcia, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R. Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten U. Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia | |
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs | 2020 | Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M. | |
Treatment of chronic lymphocytic leukemia in the new drugs era: the state of art in the Italian landscape | 2020 | Morelli F, Innocenti I, Autore F, Fresa F, Tomasso A, Piciocchi A, Frustaci AM, Trentin L, Mauro FR, Schiattone L, Visentin A, Del Poeta G, Reda G, Rigolin GM, Ibatici A, Ciolli S, Vitale C, Sportoletti P, Murru R, Levato L, Gentile M, D’Arena G, Coscia M, Villa MR, Fontana R, Efremov D, Tedeschi A, Scarfò L, Cuneo A, Foà R, Laurenti L | |
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice | 2020 | Cerrano M.; Ruella M.; Perales M.-A.; Vitale C.; Faraci D.G.; Giaccone L.; Coscia M.; Maloy M.; Sanchez-Escamilla M.; Elsabah H.; Fadul A.; Maffini E.; Pittari G.; Bruno B. | |
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia | 2020 | Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, Coscia M | |
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy | 2020 | Porrazzo M.; Nicolai E.; Riminucci M.; Vitale C.; Coscia M.; De Paoli L.; Rago A.; Buscicchio G.; Maestrini G.; Ligia S.; Di Prima A.; Corsi A.; Caronna R.; Gaidano G.; Mauro F.R. | |
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL) | 2020 | Mauro F.R.; Giannarelli D.; Galluzzo C.M.; Vitale C.; Visentin A.; Riemma C.; Rosati S.; Porrazzo M.; Pepe S.; Coscia M.; Trentin L.; Gentile M.; Raponi S.; Micozzi A.; Gentile G.; Baroncelli S. | |
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells | 2020 | Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M. | |
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus | 2020 | Scarfo L.; Chatzikonstantinou T.; Rigolin G.M.; Quaresmini G.; Motta M.; Vitale C.; Garcia-Marco J.A.; Hernandez-Rivas J.A.; Miras F.; Baile M.; Marquet J.; Niemann C.U.; Reda G.; Munir T.; Gimeno E.; Marchetti M.; Quaglia F.M.; Varettoni M.; Delgado J.; Iyengar S.; Janssens A.; Marasca R.; Ferrari A.; Cuellar-Garcia C.; Itchaki G.; Spacek M.; De Paoli L.; Laurenti L.; Levin M.-D.; Lista E.; Mauro F.R.; Simkovic M.; Van Der Spek E.; Vandenberghe E.; Trentin L.; Wasik-Szczepanek E.; Ruchlemer R.; Bron D.; De Paolis M.R.; Del Poeta G.; Farina L.; Foglietta M.; Gentile M.; Herishanu Y.; Herold T.; Jaksic O.; Kater A.P.; Kersting S.; Malerba L.; Orsucci L.; Popov V.M.; Sportoletti P.; Yassin M.; Pocali B.; Barna G.; Chiarenza A.; dos Santos G.; Nikitin E.; Andres M.; Dimou M.; Doubek M.; Enrico A.; Hakobyan Y.; Kalashnikova O.; Ortiz Pareja M.; Papaioannou M.; Rossi D.; Shah N.; Shrestha A.; Stanca O.; Stavroyianni N.; Strugov V.; Tam C.; Zdrenghea M.; Coscia M.; Stamatopoulos K.; Rossi G.; Rambaldi A.; Montserrat E.; Foa R.; Cuneo A.; Ghia P. | |
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab | 2020 | Gentile M.; Martino E.A.; Visentin A.; Coscia M.; Reda G.; Sportoletti P.; Mauro F.R.; Laurenti L.; Varettoni M.; Murru R.; Chiarenza A.; Vigna E.; Mendicino F.; Lucia E.; Bossio S.; Recchia A.G.; Moia R.; Pietrasanta D.; Loseto G.; Consoli U.; Scortechini I.; Rossi F.M.; Zucchetto A.; Al-Janazreh H.; Vitale C.; Tripepi G.; D'Arrigo G.; Angeletti I.; Bomben R.; Neri A.; Cutrona G.; Fronza G.; Di Raimondo F.; Gaidano G.; Cuneo A.; Foa R.; Ferrarini M.; Trentin L.; Gattei V.; Morabito F. | |
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights | 2020 | Salvetti C, Vitale C, Griggio V, Drandi D, Bonello L, Cavallo F, Bomben R, Gattei V, Zamò A, Coscia M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile